STOCK TITAN
  1. Home
  2. Sec-filings
  3. AVR
  4. [EFFECT] Anteris Technologies Global Corp. SEC Filing

[EFFECT] Anteris Technologies Global Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 11, 2025 4:00 P.M.
Form: S-1
CIK: 0002011514
Company Name: Anteris Technologies Global Corp.
File Number: 333-291821

Source: View Original Filing on SEC EDGAR

Stock AVR logo
ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR

AVR Rankings

#4315 Ranked by Market Cap
N/A Ranked by Dividends

AVR Latest News

Nov 17, 2025
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
Nov 12, 2025
Anteris Announces Results for the Third Quarter of 2025
Nov 3, 2025
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Oct 28, 2025
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
Oct 27, 2025
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

AVR Latest SEC Filings

Dec 17, 2025
[424B3] Anteris Technologies Global Corp. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 18, 2025
[Form 4] Anteris Technologies Global Corp. Insider Trading Activity
Dec 18, 2025
[Form 4] Anteris Technologies Global Corp. Insider Trading Activity
Dec 18, 2025
[Form 4] Anteris Technologies Global Corp. Insider Trading Activity
Dec 18, 2025
[Form 4] Anteris Technologies Global Corp. Insider Trading Activity

AVR Stock Data

225.35M
39.42M
0.21%
47.59%
2.29%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Australia
EAGAN